This molecular triad contributes to the pathogenesis of PPD by affecting synaptic plasticity, as evidenced by alterations in synapse-related proteins (e.g., SYP, SYN, and PSD95) and glutamate receptor expression. The gene discussed is SYP; the disease is progressive pseudorheumatoid arthropathy of childhood.